Knowledge and awareness of human papillomavirus (HPV): attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia
Marian K. Pitts A D , Suzanne J. Dyson A , Doreen A. Rosenthal B and Suzanne M. Garland C
A Australian Research Centre in Sex, Health and Society, La Trobe University, 215 Franklin Street, Melbourne, Vic. 3000, Australia.
B Key Centre for Women’s Health in Society, University of Melbourne, Melbourne, Vic. 3010, Australia.
C Department of Microbiology and Infectious Diseases, Royal Women’s Hospital, 132 Grattan Street, Carlton, Vic. 3053, Australia.
D Corresponding author. Email: firstname.lastname@example.org
Sexual Health 4(3) 177-180 http://dx.doi.org/10.1071/SH07023
Submitted: 13 April 2007 Accepted: 5 July 2007 Published: 23 August 2007
Background: A vaccine program is underway to protect women against human papillomavirus (HPV) and thus cervical cancer. Previous studies have reported very low levels of HPV knowledge and there has been concern that preventative vaccines might not be readily accepted, given that HPV is transmitted sexually and the optimal time for vaccination is before sexual debut. Methods: A computer-assisted telephone survey was carried out with a representative sample of 1100 women aged 18 to 61 years, randomly selected from households in Victoria, Australia, to investigate knowledge and attitudes about HPV and attitudes towards HPV vaccination. Results: Half of the participants (51%) had heard of HPV; most reported learning about it from the media. Most women indicated they would trust their general practitioner (96.3%), a gynaecologist or specialist doctor (99.6%), or a women’s health service (97.0%) for information about HPV. Few women (11.9%) had ever sought information about HPV and only 14.8% of the total sample had ever discussed HPV with a friend. Strong support was found for vaccination in general and there was also significant support for a HPV vaccine. Conclusion: The present study documents ways in which women learn about HPV and indicates the potential for success of a vaccination program.
Additional keywords: cervical cancer.
A controlled trial of a human papillomavirus type 16 vaccine.
N Engl J Med
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. GlaxoSmithKline HPV vaccine study group.
IDSA abstract Oct 2005 43rd Annual meeting of IDSA, October 6–9 2005, San Francisco, Prophylactic quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine (Gardasil) reduces cervical intraepithelial neoplasia (CIN) 2/3 risk Skjeldestad F for the Future II Steering Committee; Dept of Epidemiology, SINTEF Health Research, Trondheim, Norway.
Efficacy of a prophylactic quadrivalent human papillomavirus (HPV) (Types 6, 11, 16, 18) L1 Virus-like particle (VLP) vaccine for Prevention of cervical dysplasia and external genital lesions (EGL) D Harper, for the FUTURE Investigators. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2005 December 16–19; Washington, DC.
Knowledge of human papillomavirus infection among young adult men and women: implication for the health education and research.
J Community Health
. An assessment of college students’ knowledge and perception of risk regarding human papilloma virus and related health promotion strategies for campus health personnel. [Ph.D]: Ohio University, 1998.
Adults’ knowledge and behaviors related to human papillomavirus infection.
J Am Board Fam Pract
Attitudes of adolescent/young adult women towards human papillomavirus vaccination and clinical trials.
Health Care Women Int
Human papillomavirus, genital warts, Pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women.
Health Care Women Int
Human papillomavirus infections and risks of cervical cancer: what do women know?
Health Educ Res
Awareness of human papillomavirus among women attending a well women clinic.
Sex Transm Infect
Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.
Acta Obstet Gynecol Scand
Knowledge and acceptance of human papillomavirus vaccination: perspectives of young Australians living in Melbourne, Australia.
Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes.
Human papillomavirus vaccines: challenges to implementation.